Not too shabby; Nasdaq
(INDEXNASDAQ:.IXIC) today opens above 4,000 for the first time this millennium. (September 7, 2000, the last occasion the bourse broke that barrier, was technically the final year of the 20th century, lest William Safire’s “Gotcha! Gang”
go after me.) Sapphires? Actually it was diamonds, dahling, that topped the S&P 500 Index
(INDEXSP:.INX) in the shape of Tiffany & Co.'s
(NYSE:TIF) 8.68% break-out to a historic best. They sell love and marriage, which go together like, well, Spam meat and Skippy peanut butter
for Hormel Foods
(NYSE:HRL), which, up 5.91%, hit a fresh peak of its own. On a day Dow
(INDEXDJX:.DJI) component Goldman Sachs
(NYSE:GS), still doing “God’s work”, reached a multi-year high, the Pope assailed unfettered capitalism
. Hours later, a book of Biblical psalms sold for $14.2 million
. (How Barnes & Noble
(NYSE:BKS), which fell 5.96% even as US stock markets rose to records, could use that kind of cash.) Even Communist China now worships the Almighty Dollar, to judge by that fellow who just proposed with a bouquet of banknotes
. Who says romance is dead? His timing was impeccable, too; De La Rue
(LON:DLAR), the planet’s biggest printer of such items, jumped 9.92% after announcing earnings.
Other than Frontline
(NYSE:FRO), which reported results three hours ago, it is slim pickings for earnings announcements today. In terms of economic events that may move US stock markets this morning, at 9:55 a.m. Eastern the University of Michigan’s final figure for November consumer confidence is expected to post an improvement from the preliminary pace announced earlier in the month. At 10:00 a.m., analysts expect October leading indicators to slip from September’s rate. US markets will be closed tomorrow in observance of Thanksgiving.
: Piper Jaffray has a new Neutral on Mannkind
(NASDAQ:MNKD), but begins more upbeat Overweights on Amgen
(NASDAQ:AMGN) -- Amgen is the world’s biggest biotech and Amgen stock has advanced 30.23% in the past 12 months -- Biogen Idec
(NASDAQ:BIIB), Biomarin Pharmaceutical
(NASDAQ:BMRN), Gilead Sciences
(NASDAQ:GILD), and Incyte
(NYSE:FUN): Cedar Fair, an Ohio-based theme park operator, is assigned an upbeat pre-Turkey Day Outperform at FBR Capital. Its price objective is $70, and the broker praises FUN’s master limited partnership structure. Stock in Cedar Fair is trading near historic highs.
Emerge Energy Services
(NYSE:EMES): William Blair launches the limited partnership at an Outperform, citing its good growth prospects.
(NASDAQ:MBVT): Shares are begun with a Buy at Sterne Agee, whose price objective is $36.
(NYSE:RKUS): Ruckus Wireless is resumed with a Buy at Stifel. On Tuesday, Ruckus Wireless stock rose 1.44%, and it is advancing another 2.77% as I write this article.
(NYSE:SEAS): FBR Capital covers the stock at Market Perform.
Six Flags Entertainment
(NYSE:SIX): The stock is a new Market Perform, also at FBR.
(NYSE:TWTR): Twitter is begun with a Buy at Miller Tabak. Yesterday, stock in Twitter gained 2.87%.
(See also: Stock Upgrades: Hewlett-Packard Parties Like It's 1939
, and Stock Downgrades: Tilly's Is a Total Turkey
No positions in stocks mentioned.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.
Copyright 2011 Minyanville Media, Inc. All Rights Reserved.